Results 201 to 210 of about 94,250 (267)

PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors. [PDF]

open access: yesESMO Open
Yap TA   +12 more
europepmc   +1 more source

A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors. [PDF]

open access: yesClin Cancer Res
Siu LL   +8 more
europepmc   +1 more source

Testing new anticancer drugs before curative locoregional therapies: MDICT 2024 recommendations. [PDF]

open access: yesESMO Open
Methodology for the Development of Innovative Cancer Therapies Taskforce. Electronic address: lseymour@ctg.queensu.ca.
europepmc   +1 more source

Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity. [PDF]

open access: yesOncologist
Torrado C   +24 more
europepmc   +1 more source

Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit. [PDF]

open access: yesCancer Res Commun
Braganca Xavier C   +18 more
europepmc   +1 more source

Catálogo de los efectos geológicos de los terremotos en España. 2.ª Edición (Revisada y ampliada). Serie Riesgos Geológicos y Geotecnia nº 6

open access: green, 2019
Pablo Gabriel Silva   +12 more
openalex   +1 more source

Home - About - Disclaimer - Privacy